COMPANY INVOLVEMENT

  • Deerland Enzymes & Probiotics
  • Renaissance Acquisition Holdings
  • Revision Skincare / Goodier Cosmetics
  • Santa Cruz Nutritionals

David J. Koo

Senior Transaction Partner

Mr. Koo is a Senior Transaction Partner and has been at the firm since its inception. He is focused on the firm’s pharmaceutical related investments and is involved in all aspects of the transaction process, including deal sourcing, transaction structuring, valuation, due diligence, negotiations, financing, and execution. Mr. Koo serves on the boards of directors of Revision Skincare/Goodier Cosmetics, Renaissance Pharmaceuticals, Santa Cruz Nutritionals and Deerland Enzymes and Probiotics. He previously served on the boards of directors of Aqua, Avalign, Bioniche Pharma, CorePharma, MedAssist, and Vesta. Additionally, he was very involved throughout the Sabex investment as well as the investments in Vanguard and Argon. Mr. Koo joined RoundTable as a Principal.

PROFESSIONAL EXPERIENCE

  • Senior Transaction Partner, RoundTable, May 2006 – Present
  • Partner, RoundTable, February 2005 – April 2006
  • Principal, RoundTable, February 2001 – January 2005
  • Vice President, CSFB, U.S. Health Care Investment Banking Group, 1999 – 2001
  • Various Investment Banking Positions, CSFB, 1994 – 1999
  • Staff Accountant, KPMG Peat Marwick, Audit Department, 1993 – 1994


ACADEMIC BACKGROUND

  • Bachelor’s degree in Business Administration in Accountancy, University of Notre Dame, 1993
  • Certified Public Accountant (CPA), Illinois, 1993